These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 14516001)

  • 21. Metabolism of hyperforin, the active constituent of St. John's wort, in human liver microsomes.
    Hokkanen J; Tolonen A; Mattila S; Turpeinen M
    Eur J Pharm Sci; 2011 Feb; 42(3):273-84. PubMed ID: 21168483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The main components of St John's Wort inhibit low-density lipoprotein atherogenic modification: a beneficial "side effect" of an OTC antidepressant drug?
    Laggner H; Schreier S; Hermann M; Exner M; Mühl A; Gmeiner BM; Kapiotis S
    Free Radic Res; 2007 Feb; 41(2):234-41. PubMed ID: 17364950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of hyperforin content of Hypericum perforatum (St John's Wort) extracts with their effects on alcohol drinking in C57BL/6J mice: a preliminary study.
    Wright CW; Gott M; Grayson B; Hanna M; Smith AG; Sunter A; Neill JC
    J Psychopharmacol; 2003 Dec; 17(4):403-8. PubMed ID: 14870952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].
    Vacek J; Klejdus B; Kubán V
    Ceska Slov Farm; 2007 Apr; 56(2):62-6. PubMed ID: 17619301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperforin accumulates in the translucent glands of Hypericum perforatum.
    Soelberg J; Jørgensen LB; Jäger AK
    Ann Bot; 2007 Jun; 99(6):1097-100. PubMed ID: 17468113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperforin.
    Beerhues L
    Phytochemistry; 2006 Oct; 67(20):2201-7. PubMed ID: 16973193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of the St. John's wort constituent hyperforin on docetaxel metabolism by human hepatocyte cultures.
    Komoroski BJ; Parise RA; Egorin MJ; Strom SC; Venkataramanan R
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6972-9. PubMed ID: 16203790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a high-performance liquid chromatographic method with electrochemical detection for the determination of hyperforin.
    Rückert U; Eggenreich K; Wintersteiger R; Wurglics M; Likussar W; Michelitsch A
    J Chromatogr A; 2004 Jul; 1041(1-2):181-5. PubMed ID: 15281267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperforin, possibly the major non-nitrogenous secondary metabolite of Hypericum perforatum L.
    Erdelmeier CA
    Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():2-6. PubMed ID: 9684941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line.
    Tian R; Koyabu N; Morimoto S; Shoyama Y; Ohtani H; Sawada Y
    Drug Metab Dispos; 2005 Apr; 33(4):547-54. PubMed ID: 15640377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Downregulation of β1 -adrenergic receptors in rat C6 glioblastoma cells by hyperforin and hyperoside from St John's wort.
    Jakobs D; Hage-Hülsmann A; Prenner L; Kolb C; Weiser D; Häberlein H
    J Pharm Pharmacol; 2013 Jun; 65(6):907-15. PubMed ID: 23647684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypericum perforatum, a source of neuroactive lead structures.
    Verotta L
    Curr Top Med Chem; 2003; 3(2):187-201. PubMed ID: 12570773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperforin and its analogues inhibit CYP3A4 enzyme activity.
    Lee JY; Duke RK; Tran VH; Hook JM; Duke CC
    Phytochemistry; 2006 Dec; 67(23):2550-60. PubMed ID: 17083953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a simple, rapid and reproducible HPLC assay for the simultaneous determination of hypericins and stabilized hyperforin in commercial St. John's wort preparations.
    de los Reyes GC; Koda RT
    J Pharm Biomed Anal; 2001 Dec; 26(5-6):959-65. PubMed ID: 11600308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combining PARAFAC analysis of HPLC-PDA profiles and structural characterization using HPLC-PDA-SPE-NMR-MS experiments: commercial preparations of St. John's Wort.
    Schmidt B; Jaroszewski JW; Bro R; Witt M; Staerk D
    Anal Chem; 2008 Mar; 80(6):1978-87. PubMed ID: 18260653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of a methanolic extract and a hyperforin-enriched CO2 extract of St. John's Wort (Hypericum perforatum) on intracerebral field potentials in the freely moving rat (Tele-Stereo-EEG).
    Dimpfel W; Schober F; Mannel M
    Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():30-5. PubMed ID: 9684945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biosynthesis of the hyperforin skeleton in Hypericum calycinum cell cultures.
    Klingauf P; Beuerle T; Mellenthin A; El-Moghazy SA; Boubakir Z; Beerhues L
    Phytochemistry; 2005 Jan; 66(2):139-45. PubMed ID: 15652570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hyperforin in St. John's wort--drug, extraction and preparations].
    Lang F; Biber A; Erdelmeier C
    Pharm Unserer Zeit; 2002; 31(5):512-4. PubMed ID: 12369170
    [No Abstract]   [Full Text] [Related]  

  • 39. Variation of hyperforin in Hypericum montbretii during its phenological cycle.
    Cirak C; Radusiene J
    Nat Prod Res; 2007 Nov; 21(13):1151-6. PubMed ID: 17987494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of hyperforin in mouse brain by high-performance liquid chromatography/tandem mass spectrometry.
    Keller JH; Karas M; Müller WE; Volmer DA; Eckert GP; Tawab MA; Blume HH; Dingermann T; Schubert-Zsilavecz M
    Anal Chem; 2003 Nov; 75(22):6084-8. PubMed ID: 14615985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.